several combination therapies . However , growing resistance to antibiotics and drying pipeline has increased demand for novel treatment options for which cattle do not develop resistance , and consequently there is no impact on human life .
Development of newer generation antibiotics for cattle is anticipated to drive the global bovine respiratory disease treatment market during the forecast period . In order to avoid the issue of antibiotics resistance in bovine population , preventive measures such as vaccination and immunomodulators has observed increased global acceptance against the bovine respiratory disease . Hence , preventive treatment is gaining momentum due to growing awareness about the negative impact of antibiotics on human health . This has driven the market for immunomodulators , vitamin injections , and other immunity building products .
In terms of disease type , the market has been segmented into upper respiratory tract infections , diphtheria , and pneumonia ( lower respiratory tract infection ). Upper respiratory tract infections dominated the global bovine respiratory disease market , accounting for significant share in terms of revenue in 2015 . Respiratory infections first affect the upper respiratory tract , which is also the most vulnerable region , followed by other parts of the respiratory tract . Diphtheria accounted for significant share of the bovine respiratory disease treatment market in 2015 . Pneumonia ( lower respiratory tract infection ) accounted for high market share , followed after upper respiratory tract infection in 2015 . Hence , early detection of infection is important in bovine respiratory diseases treatment .
In terms of distribution channel , the global bovine respiratory disease treatment market has been segmented into veterinary hospitals , veterinary clinics , private veterinary pharmacies , and veterinary research institutes . Veterinary hospitals dominated the global bovine respiratory disease market in 2015 . The segment dominated the market due to factors such as rising population of cattle which increases prevalence of bovine respiratory diseases . The private veterinary pharmacies distribution channel segment is projected to register significant CAGR during the forecast period . The segment is likely to witness strong growth in most of the emerging parts of the world and preference for medicines from private veterinary pharmacies for bovine serum respiratory diseases . However , the veterinary clinics and veterinary research institutes segments are expected to grow steadily as majority of procedures are carried out in veterinary hospitals .
Global Bovine Respiratory Disease Treatment Market : Geographical and Competitive Dynamics Geographically , the bovine respiratory disease treatment market has been categorized in five major regions : North America , Europe , Latin America , Asia Pacific , and Middle East & Africa . North America held the major share of the global bovine respiratory disease treatment market in 2015 , where the U . S . dominates the market in terms of revenue . Europe accounted for a significant share of the market in 2015 . Changing environmental factors , growing prevalence of causative agents for respiratory disease , increasing demand for quality bovine products , and rising bovine population are the key factors driving the bovine respiratory disease treatment market in Europe . Asia Pacific is the largest producer of bovine livestock . Hence , it presents significant opportunities in the bovine respiratory disease treatment market . India and China are the key markets for bovine respiratory disease treatment , as these have largest livestock population compared to other countries across the globe . Latin America and Middle East & Africa have comparatively smaller markets for bovine respiratory disease treatment . However , Brazil , Mexico , and Argentina are the emerging markets in Latin America due to significant number of livestock population .
Key players operating in the global bovine respiratory disease treatment market are Merck & Co ., Inc ., Zoetis Services LLC , Bayer AG , Elanco , Merial , Boehringer Ingelheim GmbH , Virbac Group , Ceva , Vetoquinol , and Bimeda Animal Health , among others .